Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects

Atherosclerosis

Volumn 197, Issue 1, 2008, Pages 271-277

  Ruotsalainen, Eija ^a   Vauhkonen, Ilkka ^a   Salmenniemi, Urpu ^b   Pihlajamäki, Jussi ^a   Punnonen, Kari ^a   Kainulainen, Sakari ^a   Jalkanen, Sirpa ^c   Salmi, Marko ^d   Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Adhesion molecules; Endothelial dysfunction; Inflammation; Insulin resistance; Offspring of type 2 diabetic patients; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ADHESION PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ABDOMINAL FAT; ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY;

ADULT; AMINE OXIDASE (COPPER-CONTAINING); BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; E-SELECTIN; ENDOTHELIUM, VASCULAR; FAMILY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; MALE; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1; VASCULITIS;

EID: 39449139083     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.04.021     Document Type: Article

References (30)

1. Laakso M. Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med 249 (2001) 225-235
2. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., and Patterson J.K. Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 319 (1988) 1297-1301
3. Meigs J.B., Hu F.B., Rifai N., and Manson J.E. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291 (2004) 1978-1986
4. Thorand B., Baumert J., Chambless L., et al. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol 26 (2006) 398-405
5. Halcox J.P., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002) 653-658
6. Behrendt D., and Ganz P. Endothelial function. From vascular biology to clinical applications. Am J Cardiol 90 (2002) 40L-48L
7. Bluher M., Unger R., Rassoul F., Richter V., and Paschke R. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes. Diabetologia 45 (2002) 210-216
8. Chen N.G., Holmes M., and Reaven G.M. Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers. J Clin Endocrinol Metab 84 (1999) 3485-3489
9. Steiner M., Reinhardt K.M., and Blann A.D. Soluble adhesion molecules in NIDDM: increased concentration, relation to glycometabolic control and possible pathophysiological significance. Diabetologia 39 (1996) 868-870
10. Jager A., Van H.V., Kostense P.J., et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes 49 (2000) 485-491
11. Erbe D.V., Wolitzky B.A., Presta L.G., et al. Identification of an E-selectin region critical for carbohydrate recognition and cell adhesion. J Cell Biol 119 (1992) 215-227
12. Salmi M., and Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257 (1992) 1407-1409
13. Salmi M., Stolen C., Jousilahti P., et al. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. Am J Pathol 161 (2002) 2255-2262
14. Obata T. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review. Life Sci 79 (2006) 417-422
15. Caballero A.E., Arora S., Saouaf R., et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48 (1999) 1856-1862
16. McSorley P.T., Young I.S., McEneny J., and Fee H. McCance DR: susceptibility of low-density lipoprotein to oxidation and circulating cell adhesion molecules in young healthy adult offspring of parents with type 2 diabetes. Metabolism 53 (2004) 755-759
17. McEleavy O.D., McCallum R.W., Petrie J.R., et al. Higher carotid-radial pulse wave velocity in healthy offspring of patients with type 2 diabetes. Diabet Med 21 (2004) 262-266
18. Balletshofer B.M., Rittig K., Enderle M.D., et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101 (2000) 1780-1784
19. Bannan S., Mansfield M.W., and Grant P.J. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia 41 (1998) 460-466
20. Bevilacqua M.P. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 11 (1993) 767-804
21. Vauhkonen I., Niskanen L., Vanninen E., et al. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 101 (1998) 86-96
22. Salmenniemi U., Ruotsalainen E., Pihlajamaki J., et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110 (2004) 3842-3848
23. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 37 (1988) 287-301
24. Kurkijarvi R., Adams D.H., Leino R., et al. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol 161 (1998) 1549-1557
25. Rohde L.E., Hennekens C.H., and Ridker P.M. Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 19 (1999) 1595-1599
26. Ferri C., Desideri G., Baldoncini R., et al. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes 47 (1998) 660-667
27. Targher G., Bonadonna R.C., Alberiche M., et al. Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. Diabetes Care 24 (2001) 1961-1966
28. Wang H.W., Babic A.M., Mitchell H.A., Liu K., and Wagner D.D. Elevated soluble ICAM-1 levels induce immune deficiency and increase adiposity in mice. FASEB J 19 (2005) 1018-1020
29. Brake D.K., O'Brian S., Mersmann C., Smith C.W., and Robker R.L. ICAM-1 expression in adipose tissue: effects of diet induced obesity in mice. Am J Physiol Cell Physiol 291 (2006) 1232-1239
30. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91